Creema Ltd.
Creema Ltd. Fundamental Analysis
Creema Ltd. (4017.T) shows weak financial fundamentals with a PE ratio of 39.25, profit margin of 1.57%, and ROE of 3.52%. The company generates $2.5B in annual revenue with weak year-over-year growth of -0.08%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 27.7/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze 4017.T's fundamental strength across five key dimensions:
Efficiency Score
Weak4017.T struggles to generate sufficient returns from assets.
Valuation Score
Moderate4017.T shows balanced valuation metrics.
Growth Score
Moderate4017.T shows steady but slowing expansion.
Financial Health Score
Excellent4017.T maintains a strong and stable balance sheet.
Profitability Score
Weak4017.T struggles to sustain strong margins.
Key Financial Metrics
Is 4017.T Expensive or Cheap?
P/E Ratio
4017.T trades at 39.25 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, 4017.T's PEG of -0.68 indicates potential undervaluation.
Price to Book
The market values Creema Ltd. at 1.41 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 43.86 times EBITDA. This signals the market has high growth expectations.
How Well Does 4017.T Make Money?
Net Profit Margin
For every $100 in sales, Creema Ltd. keeps $1.57 as profit after all expenses.
Operating Margin
Core operations generate 1.98 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $3.52 in profit for every $100 of shareholder equity.
ROA
Creema Ltd. generates $1.08 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Creema Ltd. generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.
Free Cash Flow
Creema Ltd. generates weak or negative free cash flow of $0.00, restricting financial flexibility.
FCF Per Share
Each share generates $0.00 in free cash annually.
FCF Yield
4017.T converts 0.00% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
39.25
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-0.68
vs 25 benchmark
P/B Ratio
Price to book value ratio
1.41
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.61
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.42
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.45
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.04
vs 25 benchmark
ROA
Return on assets percentage
0.01
vs 25 benchmark
ROCE
Return on capital employed
0.04
vs 25 benchmark
How 4017.T Stacks Against Its Sector Peers
| Metric | 4017.T Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 39.25 | 23.72 | Worse (Expensive) |
| ROE | 3.52% | 1091.00% | Weak |
| Net Margin | 1.57% | -629.00% (disorted) | Weak |
| Debt/Equity | 0.42 | 0.72 | Strong (Low Leverage) |
| Current Ratio | 1.45 | 2.64 | Neutral |
| ROA | 1.08% | 1050.00% | Weak |
4017.T outperforms its industry in 1 out of 6 key metrics, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Creema Ltd.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
49.34%
Industry Style: Cyclical, Growth, Discretionary
High GrowthEPS CAGR
432.20%
Industry Style: Cyclical, Growth, Discretionary
High GrowthFCF CAGR
112.59%
Industry Style: Cyclical, Growth, Discretionary
High Growth